amplicon strategy midnight-bccdc-v3 strategy 2026-04-13T19:52:38.515Z An amplicon strategy which targets SARS-CoV-2 and is based on the original Midnight scheme developed by Oxford Nanopore Technologies, and adapted by the BCCDC Public Health Lab with the attributes of version 3.0.0 which produces amplicons approximately 1200bp in length. midnight bccdc v3 midnight-bccdc-v3 requires discussion